Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.95 USD | +0.92% | +29.71% | +177.09% |
04-22 | Benitec Biopharma Inc. announced that it has received $40.000019 million in funding from a group of investors | CI |
04-18 | Sector Update: Health Care Stocks Mixed in Late Afternoon Trading | MT |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jerel Banks
CEO | Chief Executive Officer | 49 | 16-09-30 |
Peter Roelvink
CTO | Chief Tech/Sci/R&D Officer | - | 15-02-28 |
Megan Boston
CMP | Compliance Officer | 52 | 16-07-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
J. Buchi
BRD | Director/Board Member | 69 | 13-03-31 |
Edward Smith
BRD | Director/Board Member | 53 | 20-04-13 |
Peter Francis
BRD | Director/Board Member | 68 | 06-01-31 |
Jerel Banks
CEO | Chief Executive Officer | 49 | 16-09-30 |
Megan Boston
CMP | Compliance Officer | 52 | 16-07-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 8,341,586 | 7,472,030 ( 89.58 %) | 0 | 89.58 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+177.09% | 76.07M | |
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- BNTC Stock
- Company Benitec Biopharma Inc.